Japanese team creates cancer-specific killer T cells from induced pluripotent stem cells
Written by Lorraine Carolan | 11 Feb 2013
World Health Matters – Japan – by Eoghan McNeill – Researchers from the RIKEN Research Centre for Allergy and Immunology in Japan report today that they have succeeded… read more.
Could obesity make Alzheimer’s worse?
Written by Gary Finnegan | 11 Feb 2013
World Health Matters – France – by Gary Finnegan – The detrimental effects of obesity are well-documented with public health specialists warning of a tidal wave of diabetes… read more.
‘Second-hand smoke’ increases dementia risk
Written by Gary Finnegan | 11 Feb 2013
World Health Matters – China – by Gary Finnegan – A study of nearly 6,000 people in five provinces in China has shown that people exposed to passive… read more.
‘Fat tax’ could improve behaviour
Written by Gary Finnegan | 11 Feb 2013
World Health Matters – New Zealand – by Gary Finnegan – Taxes on sugary drinks and foods high in saturated fats, along with subsidies for fruit and vegetables,… read more.
Drug companies facing higher fees
Written by Gary Finnegan | 8 Feb 2013
EMA Highlights by Gary Finnegan – Pharmaceutical companies will have to pay more to have their new medicines evaluated, if the European Medicines Agency is to balance its… read more.
Green light for new medicines
Written by Gary Finnegan | 8 Feb 2013
EMA Highlights by Gary Finnegan – Several new medicines have been approved by the EMA’s influential Committee for Medicinal Products for Human Use (CHMP), including the first non-surgical… read more.
New guideline on cancer medicines
Written by Lorraine Carolan | 8 Feb 2013
EMA Highlights by Eoghan McNeill – The EMA has published revised guidelines on the evaluation of anti-cancer medicines to take account of advances in research and new therapeutic… read more.
Psoriasis drug shows potential for crohn’s disease
Written by Bruce Sylvester | 7 Feb 2013
Taken from the New England Journal of Medicine (NEJM) – by Bruce Sylvester – Ustekinumab, a drug used to treat psoriasis, appears to decrease the debilitating effects of… read more.
Psoriasis drug shows potential for crohn's disease
Written by Bruce Sylvester | 7 Feb 2013
Taken from the New England Journal of Medicine (NEJM) – by Bruce Sylvester – Ustekinumab, a drug used to treat psoriasis, appears to decrease the debilitating effects of… read more.
Daily multivitamin use by men does not lower cardiovascular disease risk
Written by Bruce Sylvester | 7 Feb 2013
Taken from the Journal of the American Medical Association (JAMA) – by Bruce Sylvester – Daily multivitamin use by men does not reduce the risk of cardiovascular disease,… read more.
Rituximab appears to benefit clinical problems tied to antiphospholipid antibodies
Written by Bruce Sylvester | 7 Feb 2013
FDA Highlights by Bruce Sylvester – According to a study published online on Nov. 20, 2012 in Arthritis and Rheumatism, rituximab appears to benefit patients with antiphospholipid antibodies… read more.
Metformin treatment associated with improved survival in Ovarian Cancer
Written by Bruce Sylvester | 7 Feb 2013
FDA Highlights by Bruce Sylvester – Women with ovarian cancer and diabetes who took metformin for their diabetes have achieved a better survival rate than patients who did… read more.
Subscribe for our mailing list
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
This website uses cookies to enhance your browsing experience, analyse site traffic, and personalise content. By clicking “Accept” you consent to the use of all cookies. You can manage your preferences or withdraw consent at any time by visiting our cookie settings.
Functional Always active
Preferences
Statistics
Marketing
If you’re a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

